SCHEMBL30681042

SCHEMBL30681042

CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(C(N)=O)c3)cc2F)n(-c2ccc3ncccc3c2)n1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 7/20 0.86
▸ MAPK14 Q16539 7/20 0.86
▸ BRAF P15056 7/20 0.86
▸ SRC P12931 3/20 0.86
▸ AXL P30530 2/20 0.86
▸ RIPK1 Q13546 2/20 0.86
▸ PLK4 O00444 1/20 0.86
▸ ACOX3 O15254 1/20 0.86
▸ MAP3K7 O43318 1/20 0.86
▸ DYRK3 O43781 1/20 0.86
▸ JAK2 O60674 1/20 0.86
▸ ERN1 O75460 1/20 0.86
▸ RPS6KA4 O75676 1/20 0.86
▸ STK10 O94804 1/20 0.86
▸ MAP4K4 O95819 1/20 0.86
▸ RAF1 P04049 1/20 0.86
▸ NTRK1 P04629 1/20 0.86
▸ LCK P06239 1/20 0.86
▸ FYN P06241 1/20 0.86
▸ CDK1 P06493 1/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2029025 1.00 ABL1 (0.86) ABL1MAPK14BRAFSRCAXL
Hydrochloric Acid SCHEMBL5057169 0.99 ABL1 (0.85) ABL1MAPK14BRAFSRCAXL
Rebastinib SCHEMBL2034290 0.93 BRAF (1.00) ABL1MAPK14BRAFSRCAXL
SCHEMBL20033385 0.93 MAPK14 (0.89) ABL1MAPK14BRAFSRCAXL
Rebastinib SCHEMBL30499050 0.93 BRAF (1.00) ABL1MAPK14BRAFSRCAXL
Rebastinib SCHEMBL29733447 0.93 BRAF (1.00) ABL1MAPK14BRAFSRCAXL
Rebastinib SCHEMBL29354367 0.93 BRAF (1.00) ABL1MAPK14BRAFSRCAXL
SCHEMBL18814248 0.92 MAPK14 (0.88) ABL1MAPK14BRAFSRCAXL
Rebastinib SCHEMBL29733460 0.92 BRAF (0.99) ABL1MAPK14BRAFSRCAXL
Rebastinib SCHEMBL2026623 0.92 BRAF (0.99) ABL1MAPK14BRAFSRCAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111556747-B DUX 4-induced inhibitors for modulating muscle function 索尼克马斯特有限公司 2023-11-17 — — CN disclosed
Send feedback